ArticleDiabetes care2021

Second-Line Therapy for Type 2 Diabetes Management: The Treatment/Benefit Paradox of Cardiovascular and Kidney Comorbidities.

Rozalina G McCoy et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.